# Study to Evaluate Cinacalcet in Children With Chronic Kidney Disease

> **NCT01290029** · PHASE1 · COMPLETED · sponsor: **Amgen** · enrollment: 14 (actual)

## Conditions studied

- Chronic Kidney Disease
- Hyperparathyroidism, Secondary
- Secondary Hyperparathyroidism

## Interventions

- **DRUG:** Cinacalcet

## Key facts

- **NCT ID:** NCT01290029
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01-25
- **Primary completion:** 2015-09-23
- **Final completion:** 2015-09-23
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2020-06-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01290029

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01290029, "Study to Evaluate Cinacalcet in Children With Chronic Kidney Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01290029. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*